[go: up one dir, main page]

AR019948A1 - PATCH CONTAINING ACTIVE SUBSTANCE, FOR THE CONTROLLED ISSUANCE OF ESTRADIOL OR ITS PHARMACEUTICALLY INOFENSIVE DERIVATIVES, AND THE USES OF THE PATCH - Google Patents

PATCH CONTAINING ACTIVE SUBSTANCE, FOR THE CONTROLLED ISSUANCE OF ESTRADIOL OR ITS PHARMACEUTICALLY INOFENSIVE DERIVATIVES, AND THE USES OF THE PATCH

Info

Publication number
AR019948A1
AR019948A1 ARP990103731A ARP990103731A AR019948A1 AR 019948 A1 AR019948 A1 AR 019948A1 AR P990103731 A ARP990103731 A AR P990103731A AR P990103731 A ARP990103731 A AR P990103731A AR 019948 A1 AR019948 A1 AR 019948A1
Authority
AR
Argentina
Prior art keywords
patch
containing active
estradiol
derivatives
pharmaceutically
Prior art date
Application number
ARP990103731A
Other languages
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR019948A1 publication Critical patent/AR019948A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Un parche que contiene sustancia activa para la emision controlada de estradiol o de sus derivados farmacéuticamente inofensivos, solos o en combinacioncon gestágenos, a la piel humana o animal, a partir de una capa posterior, un deposito unido a lamisma que contiene principio activo, adecuado para la emisioncombinada de principio activo, que se fabrica utilizando adhesivos de contacto, y una capa protectora separable, que se caracteriza por el hecho de que eladhesivo de contacto contienecoles terol o almidon de maíz.A patch containing active substance for the controlled emission of estradiol or its pharmaceutically harmless derivatives, alone or in combination with gestagens, to human or animal skin, from a posterior layer, a reservoir attached to the same containing active, suitable substance for the combined emission of active ingredient, which is manufactured using contact adhesives, and a separable protective layer, which is characterized by the fact that the contact adhesive contains tercol or corn starch.

ARP990103731A 1998-07-29 1999-07-28 PATCH CONTAINING ACTIVE SUBSTANCE, FOR THE CONTROLLED ISSUANCE OF ESTRADIOL OR ITS PHARMACEUTICALLY INOFENSIVE DERIVATIVES, AND THE USES OF THE PATCH AR019948A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834006A DE19834006A1 (en) 1998-07-29 1998-07-29 Estradiol-containing patch for the transdermal application of hormones

Publications (1)

Publication Number Publication Date
AR019948A1 true AR019948A1 (en) 2002-03-27

Family

ID=7875612

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103731A AR019948A1 (en) 1998-07-29 1999-07-28 PATCH CONTAINING ACTIVE SUBSTANCE, FOR THE CONTROLLED ISSUANCE OF ESTRADIOL OR ITS PHARMACEUTICALLY INOFENSIVE DERIVATIVES, AND THE USES OF THE PATCH

Country Status (14)

Country Link
EP (1) EP1100478A1 (en)
JP (1) JP2002521426A (en)
KR (1) KR20010072071A (en)
CN (1) CN1310615A (en)
AR (1) AR019948A1 (en)
AU (1) AU762589B2 (en)
BR (1) BR9912688A (en)
CA (1) CA2338861A1 (en)
DE (1) DE19834006A1 (en)
IL (1) IL141032A0 (en)
PL (1) PL345696A1 (en)
TR (1) TR200100290T2 (en)
WO (1) WO2000006130A1 (en)
ZA (1) ZA200100721B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005047906A (en) * 2003-07-16 2005-02-24 Taisho Pharmaceut Co Ltd Anti-inflammatory analgesic composition for external use
KR100689534B1 (en) * 2005-05-18 2007-03-02 삼성전자주식회사 Handheld terminal

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (en) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE4210711A1 (en) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4229820C2 (en) * 1992-09-07 1998-12-03 Jenapharm Gmbh Progestogen-based pharmaceutical preparation
AU692504B2 (en) * 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
DE4416927C1 (en) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Device for release of active agents from melt-type adhesive

Also Published As

Publication number Publication date
AU5284299A (en) 2000-02-21
JP2002521426A (en) 2002-07-16
WO2000006130A1 (en) 2000-02-10
CN1310615A (en) 2001-08-29
EP1100478A1 (en) 2001-05-23
TR200100290T2 (en) 2001-07-23
BR9912688A (en) 2001-11-27
KR20010072071A (en) 2001-07-31
PL345696A1 (en) 2002-01-02
ZA200100721B (en) 2002-05-27
AU762589B2 (en) 2003-06-26
IL141032A0 (en) 2002-02-10
DE19834006A1 (en) 2000-02-24
CA2338861A1 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
AR021459A1 (en) PATCH CONTAINING ESTRADIOL FOR THE PERCUTANEOUS APPLICATION OF HORMONES.
ES2702231T3 (en) Dressings containing active substance
US6890553B1 (en) Exothermic topical delivery device
ES2326387T3 (en) COSMETIC TREATMENT WITH NITRIC OXIDE, DEVICE FOR CARRYING OUT SUCH TREATMENT AND MANUFACTURING PROCEDURE OF THE SAME.
ES2180658T3 (en) PREPARED FOR PERCUTANEOUS ABSORPTION.
AR042815A1 (en) ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS
EP1194092B1 (en) Exothermic topical delivery device
ES2196055T3 (en) TRANSDERMAL DEVICE CONTAINING POLYVINYLPIRROLIDONE AS A SOLUBILITY INTENSIFIER.
NO993385D0 (en) Transdermal therapeutic system for the release of hormones
ES2152979T3 (en) TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ESTRADIOL.
UY24117A1 (en) ANTIFUNGAL TREATMENT OF THE NAILS.
ES2137993T3 (en) THE USE OF GLYCERINE TO MODERATE THE TRANSDERMAL CONTRIBUTION OF MEDICINES.
BR0114909A (en) Transdermal drug delivery devices having coated microprotrusions
ES2086353T3 (en) PERCUTANEOUS THERAPEUTIC SYSTEM CONTAINING BUPRENORPHINE AS AN ACTIVE COMPONENT.
JPH05500511A (en) Transdermal delivery device with delayed onset of delivery
US11510883B2 (en) Kit for delivery of an active compound into the skin
AR042677A1 (en) ORAL CARE COMPOSITIONS AND METHODS
AR019948A1 (en) PATCH CONTAINING ACTIVE SUBSTANCE, FOR THE CONTROLLED ISSUANCE OF ESTRADIOL OR ITS PHARMACEUTICALLY INOFENSIVE DERIVATIVES, AND THE USES OF THE PATCH
PA8615501A1 (en) PHARMACEUTICAL FORMULATIONS TRANSDERMICAS
DE60126591D1 (en) In vitro use of astaxanthin to pre-treat cells from UV irradiation to inhibit the activation of NF-κB
DE60312645D1 (en) PHARMACEUTICAL FORMS FOR DNS
AR016200A1 (en) THE USE OF A COMPOSITION THAT INCLUDES ONE OR MORE COMPOUNDS CONTAINING SULFUR FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO INCREASE THE PERMEABILITY OF THE HUMAN CORN FABRIC, AND A KIT THAT INCLUDES SUCH COMPOSITION
ES2188021T3 (en) METHOD TO AVOID THE UNFAULT USE OF A PERCUTANEOUS THERAPEUTIC SYSTEM.
AR029664A1 (en) ESTRNGEN CARRIER PATCH WITH ACTIVE SUBSTANCE RESERVE BASED ON ETILCELLULOSE AND AN ETHYLENE COPOLEMER, VINYL ACETATE AND VINYLPIRROLIDONE
AR020108A1 (en) PREPARED FOR THE PERCUTANEOUS THERAPEUTIC APPLICATION OF GLICEROL TRINITRATE, A PROCEDURE FOR ITS PREPARATION AND EMPLOYMENT

Legal Events

Date Code Title Description
FA Abandonment or withdrawal